LRRK2 G2019S promotes the development of colon cancer via modulating intestinal inflammation https://www.biorxiv.org/content/10.1101/2023.06.28.546897v1?med=mas
QOTO: Question Others to Teach Ourselves An inclusive, Academic Freedom, instance All cultures welcome. Hate speech and harassment strictly forbidden.